Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02420860
Title Study of Elotuzumab With Lenalidomide as Maintenance After Autologous Stem Cell Transplant (ASCT)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

myeloid neoplasm

Therapies

Famotidine

Elotuzumab + Lenalidomide

Diphenhydramine

Dexamethasone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.